@EASLedu
brings you the latest on
#liver
research & education. Visit
#EASLCampus
-----------------
EASL does not express any political opinion.
RT ≠ endorsement
🩺✨ Dive into the complexities of
#endoscopy
with the
#EASL
&
@ESGE_news
eLearning course!
Three modules are already available!
🔹Module 1: General Aspects of Endoscopy
🔹Module 2: Endoscopy and Portal Hypertension Part 1
🔹Module 3: Endoscopy and Portal Hypertension Part 2
🥳🙌Finishing with some numbers! We reached over 25 Million impressions, thanks to you all for your great interactions and tweets! Thank you to the delegates, the chairs, speakers, poster presenters and sponsors for making the
#ILC2020
a success! See you in Amsterdam
#ILC2021
Live from the
#ILC2020
#EASLstudio
backstage! Don't forget to adress your questions to the evening and morning sessions using the
#EASLstudio
hashtag
Wishing you a great digital
#ILC2020
Frederik Nevens demonstrating that combination of OCA and Bezafibrate (BZF)
1⃣Induces biochemical remission in patients
2⃣Reduces the incidence of
#pruritus
3⃣Is better than BZF monotherapy
#EASLCongress
#LiverTwitter
📢Hear ye, Hear ye!
We have a new Social Media Advisor!
Join us in welcoming Dr Ahmed Elsharkawy!👏 👏
🤝 We look forward to working with him in sharing the hidden gems
#Livertwitter
has to offer!
Follow him 👉
@aelsharkawy75
Bio 👉 at
@EASLnews
Thanks to all for attending, sharing and interacting through
#IlC2018
and making this
#EASL
Congress a great success!!! We have reached over 35 million impressions!! 😀🙌👏 Safe travels ✈️🚆and see you in Vienna
#ILC2019
Thanks to the organisers, speakers, chairs & attendees for making the second
#EASL
#NAFLDsummit
a great success!! Thanks to the 119 twitter participants for interacting & sharing: We reached 1 Million
#impressions
!! 👏🙌😀
Wishing you all safe travels and see you next year 🌞!
Landmark paper session with
@dufour_jf
challening
@ProfJohnDillon
on his paper on intelligent liver function testing (iLFT): a trial of automated diagnosis and staging of liver disease in primary care, great discussions!
#ILC2020
#livertwitter
📢
#EASL
is organising together with
@JHepatology
2 webinars on decompensated
#cirrhosis
based on the upcoming journal supplement!
Webinar1: Disease Trajectory & Pathophysiology, 25 May.
Webinar2: Management & Liver Transplantation, 1 June.
Register now:
1⃣ Early diagnosis of HE is key:
✅Animal naming test❌PHES too long, any 🚗 accident?
2⃣ Blood ammonia test to rule out other causes of HE
3⃣ Lactulose favoured, rifaximin possible
4⃣ Brain imaging if cofactors
5⃣ Optimise diet
6⃣ AWARENESS 🆙
@ISHENliver
#LiverTwitter
@EASLnews
📢
@DocBerza
on portal hypertension:
👉frequent in patients with HCC
👉leads to poor outcomes
👉non-invasive tests are not always reliable (i.e in compensated patients)
👉novel methods are coming but validation studies are needed
#LiverCancerSummit
2023
@EASLnews
💡Advice from
@MassimoPinzani
to the
#YoungInvestigators
❌Don't study
#NAFLD
✅Go to areas with less current developement
💭Consider Big data - new technologies
👐Be open-minded and interdisciplinary
🧚♀️Find the RIGHT mentor - the wrong mentor could clip your wings
#ILC2021
🎉 WE DID IT!
The
#EASLCongress
2023 has been a remarkable event, bringing together experts, researchers, and healthcare professionals from around the world to share insights and advancements in liver research and clinical practice. From the innovative sessions and workshops
#EASLStudio
:
👉No HE without hyperammonaemia while the opposite is not necessarily true
👉 Ammonia: biomarker for patient selection but not a clinical endpoint
🧐 Treat effect of hyperammonaemia rather than ↘️ ammonia level?
@RajivJalan1
@ISHENliver
#LiverTwitter
@EASLnews
Is anticoagulation indicated in patients with cirrhosis and occlusive portal vein thrombosis❓
➡️ Prof. Agustín Albillos is answering this important question for the students of the
#EASLSchool
in Madrid 🇪🇸
#LiverTwitter
@EASLNews
@DigestivoHRyC
📢
@CancerInflam
explained why metagenomics should be used in liver cancer research:
👉Non-invasive test for NASH staging
👉Spatial distribution of bacteria in tumours
👉Identify microbial signature in cohort & mycobiome
#LiverCancerSummit
2023
#Livertwitter
@EASLnews
#EASLStudio
: Statins for cirrhotic patient?
👉 It depends on the dose: simvastatin 40mg is unsafe
👍 Better for compensated patients
❌Not recommended to prevent ACLF
👉Give statins if there are any indications for it
👍 Ok in compensated patient with MASLD with close monitoring
That’s a wrap! 🎬
Thank you very much🙏
➡️ the course organisers and local team of the Hospital Universitario Ramón y Cajal👨⚕️
➡️ our group of international students, coming from 15 different countries 🌍 for this
#EASLSchool
on cirrhosis
➡️ special guest
@ReibergerThomas
Nice talk of Dr Matías A Avila showing the importance of epigenetic alterations in hepatocarcinogenesis and why this could bring to new treatment strategies!
👉Questions? Use the Q&A tool
#LiverCancerSummit
2022
@EASLnews
📢🧪🧫New on
#EASLcampus
!
"Basic techniques in experimental hepatology at a glance"!
Discover scientific video protocols in the fields of hepatology &
#liver
-related
#research
!
Watch the 1st video on establishing organoids from patient-derived tissues!
Sugar-sweetened beverages & ⬆️
#liver
lipogenesis?
🥤It's all in the fructose
What are the implications?🤔
Hear the authors' take at the
#EASLJC
🗓️Tomorrow, 18:00 CET
More info👉
@EASLnews
@JHepatology
Live from digital
#ILC2020
General Session I with Prof.Tanaka on Bezafibrate add-on therapy improves
#liver
transplantation-free survival in patients with primary biliary cholangitis: a Japanese nationwide cohort study
#livertwitter